Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :20697806
Publication Date : //

Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection.


The occurrence of heteroplasmy and mixtures is technically challenging for the analysis of mitochondrial DNA. More than that, observed mutations need to be carefully interpreted in the light of the phylogeny as mitochondrial DNA is a uniparental marker reflecting human evolution. Earlier attempts to explain the role of mtDNA in cancerous tissues led to substantial confusion in medical genetics mainly due to the presentation of low sequence data quality and misinterpretation of mutations representing a particular haplogroup background rather than being cancer-specific. The focus of this study is to characterize the extent and level of mutations in breast cancer samples obtained by tissue microdissection by application of an evaluated full mtDNA genome sequencing protocol. We amplified and sequenced the complete mitochondrial genomes of microdissected breast cancer cells of 15 patients and compared the results to those obtained from paired non-cancerous breast tissue derived from the same patients. We observed differences in the heteroplasmic states of substitutions between cancerous and normal cells, one of which was affecting a position that has been previously reported in lung cancer and another one that has been identified in 16 epithelial ovarian tumors, possibly indicating functional relevance. In the coding region, we found full transitions in two cancerous mitochondrial genomes and 12 heteroplasmic substitutions as compared to the non-cancerous breast cells. We identified somatic mutations over the entire mtDNA of human breast cancer cells potentially impairing the mitochondrial OXPHOS system.

Authors : Fendt Liane , Niederstätter Harald , Huber Gabriela , Zelger Bettina , Dünser Martina , Seifarth Christof , Röck Alexander , Schäfer Georg , Klocker Helmut , Parson Walther ,

Related products :

Catalog number Product name Quantity
31-013 BRCA1, which functions as a tumor suppressor in human breast cancer cells, is a nuclear phosphoprotein which associates with RNA polymerase II holoenzyme. Mutations in BRCA1 are predicted to be respon 0.05 mg
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018; ihc Anti-Actin confirmed
1240 Breast cancer, matched metastatic carcinoma and cancer adjacent normal breast tissue array, including TNM, clinical stage and pathology grade, 48 cases_ 96 cores,
BR6161 High_density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases_616 cores
BR808 Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases_80 cores, replaced by BR8018
BR6161 High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases_616 cores; ihc Anti-Actin confirmed
BR808 Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases_80 cores, replaced by BR8018; ihc Anti-Actin confirmed
BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores
1106 Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BRN801
1185 Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243i
BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea_96 cores; ihc H&E, IHC anti-Cytokeratin
1114 Breast cancer tissue array with adjacent normal breast tissue as control, including TNM, clinical stage and pathology grade, 110 cases_110 cores, replacing BC081116
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243a; ihc Anti-Actin confirmed
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing BRN801; ihc Anti-Actin confirmed
Breast - BRC1502 Breast cancer array, non_overlapping with BRC1501, consists of duplicated 70 cases covering all the common types of breast cancer and 5 cases of normal and other non_malignant breast tissues. 1.1mm
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243c; ihc Anti-Actin confirmed
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replaced by BR243d; ihc Anti-Actin confirmed
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases_24 cores, replacing BR243a; ihc Anti-Actin confirmed
1133 Breast cancer tissue array with cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 190 cases_ 192 cores, replacing BR1921
Breast - BRC1501 Breast cancer array consists of duplicated 70 cases covering all the common types of breast cancer and 5 cases of normal and other non_malignant breast tissues. 1.1mm
Breast - BRC961 Breast cancer array consists of duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal and other non_malignant breast tissues. 1.5mm
1113 Breast cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC08013
Breast - BRC481 Breast cancer array, 16 cases of breast cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases_208 cores


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur